VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ACHC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ACHCAcadia Healthcare Company, Inc.
$37.00$3.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksACHCBalance Sheet

Acadia Healthcare Company, Inc. (ACHC) Balance Sheet

15Y historyFree accessUpdated daily

Total debt rose to $2.6B in Q2 2026 from $2.0B a year earlier, lifting D/E to 1.17 from 0.64, while retained earnings swung to a -$750.8M deficit, reflecting a $1.2B loss in Q4 2025.

Income StatementBalance SheetCash FlowRatios

ACHC Balance Sheet

Annual statement

ACHC Balance Sheet

Acadia Healthcare Company, Inc. (ACHC) balance sheet — 15-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Total Current Assets881.32M814.14M577.49M596M506.13M495.03M2.52B542.21M450.42M471.55M427.93M294.74M274.14M145.13M140.98M112.61M
Cash & Short-Term Investments163.31M133.24M76.31M100.07M97.65M133.81M378.7M99.53M50.51M67.29M57.06M11.21M94.04M4.57M49.4M61.12M
Cash Only163.31M133.24M76.31M100.07M97.65M133.81M378.7M99.53M50.51M67.29M57.06M11.21M94.04M4.57M49.4M61.12M
Short-Term Investments0000000000000000
Accounts Receivable501.38M545.16M421.98M429.53M353.74M304.45M297.08M321.06M318.09M344.97M314.77M239.43M134.59M106.12M63.87M35.13M
Days Sales Outstanding57.560.0748.8353.5349.4648.0151.8858.3538.5444.3940.8748.748.954.2957.2157.92
Inventory6.25M5.69M5.65M5.3M5.09M4.79M4.85M4.08M5.05M4.79M4.63M4.68M20.16M15.7M11.38M6.24M
Days Inventory Outstanding0.770.760.850.8618.5319.2620.31.251.041.061.021.6211.7912.8616.0313.56
Other Current Assets159.27M83.04M32.2M25.01M10.6M17.69M1.81B90.19M45.96M75.23M75.45M40.4M46.73M38.27M27.71M16.36M
Total Non-Current Assets4.67B4.71B5.38B4.76B4.48B4.27B3.98B6.34B5.72B5.95B5.6B3.99B1.95B1.08B842.43M300.39M
Property, Plant & Equipment3.19B3.25B2.97B2.38B2.09B1.9B1.72B1.6B3.11B3.05B2.7B1.71B1.07B370.11M236.94M82.97M
Fixed Asset Turnover1.06x1.02x1.06x1.23x1.25x1.21x1.22x1.26x0.97x0.93x1.04x1.05x0.94x1.93x1.72x2.67x
Goodwill1.32B1.3B2.26B2.23B2.22B2.2B2.11B2.09B2.4B2.75B2.68B2.13B802.99M661.55M557.4M186.81M
Intangible Assets100.19M96.67M70M73.28M76.04M70.14M68.53M68.83M88.99M87.35M83.31M59.58M21.64M20.57M15.99M8.23M
Long-Term Investments46.6M21.6M8.8M0000060.52M13M73.51M18.3M0-15.7M-11.38M0
Other Non-Current Assets67.24M50.95M43.24M72.55M92.7M94.97M79.13M2.58B64.93M49.57M51.32M20.21M41.98M27.31M32.1M16.37M
Total Assets5.55B5.53B5.96B5.36B4.99B4.77B6.5B6.88B6.17B6.42B6.02B4.29B2.22B1.22B983.41M413M
Asset Turnover0.62x0.60x0.53x0.55x0.52x0.49x0.32x0.29x0.49x0.44x0.47x0.42x0.45x0.58x0.41x0.54x
Asset Growth %-42.45%-7.21%11.16%7.44%4.61%-26.64%-5.52%11.45%-3.92%6.64%40.56%92.76%81.57%24.53%138.12%-
Total Current Liabilities552.03M525.19M577.92M885.78M388.33M404.86M1.31B463.58M416.38M377.39M342.87M290.2M165.93M114.69M71.85M40.67M
Accounts Payable138.56M150.4M232.7M156.13M104.72M98.58M87.81M90.26M117.74M102.3M80.03M91.34M48.7M36.03M19.08M8.64M
Days Payables Outstanding18.0620.1134.7825.37381.48396.68367.427.6224.1622.6217.6131.6228.4929.5126.8818.78
Short-Term Debt32.5M50.69M76.82M29.22M21.25M18.59M153.48M43.68M34.11M34.83M34.8M45.36M26.96M15.2M7.68M6.75M
Deferred Revenue (Current)9.22M2.81M1.69M2.17M6.65M30.37M35.95M1.9M32.15M31.34M28.8M146M2.07M000
Other Current Liabilities174.84M132.66M808K512.74M00744.61M148.69M111.89M108.86M93.63M64.99M3.15M23.93M16.34M9.08M
Current Ratio1.60x1.55x1.00x0.67x1.30x1.22x1.93x1.17x1.08x1.25x1.25x1.02x1.65x1.27x1.96x2.77x
Quick Ratio1.59x1.54x0.99x0.67x1.29x1.21x1.93x1.16x1.07x1.24x1.23x1.00x1.53x1.13x1.80x2.62x
Cash Conversion Cycle40.2140.7114.929.02-313.48-329.41-295.2231.9815.4222.8324.2918.732.237.6446.3752.69
Total Non-Current Liabilities2.75B2.86B2.19B1.59B1.7B1.78B3.29B3.91B3.42B3.47B3.51B2.31B1.18B629.26M479.01M275.96M
Long-Term Debt2.32B2.47B1.88B1.34B1.36B1.48B2.97B3.11B3.16B3.21B3.25B2.2B1.07B601.94M465.64M270.71M
Capital Lease Obligations512.44M132.68M101.83M111.7M116.43M116.84M84.03M85.64M00000000
Deferred Tax Liabilities324.29M66.61M83.95M1.93M92.59M74.37M50.02M22.82M80.37M80.33M78.52M23.94M63.88M7.97M998K6.01M
Other Non-Current Liabilities207.15M190.89M122.3M129.22M125.03M110.5M188.73M696.3M154.27M166.43M164.86M86.66M43.51M19.35M12.38M5.25M
Total Liabilities3.3B3.39B2.77B2.47B2.09B2.19B4.6B4.37B3.84B3.85B3.86B2.6B1.34B743.95M550.86M316.63M
Total Debt2.5B2.65B2.09B1.51B1.53B1.64B3.26B3.26B3.19B3.24B3.29B2.24B1.1B617.14M473.32M277.46M
Net Debt2.34B2.52B2.01B1.41B1.43B1.5B2.88B3.16B3.14B3.17B3.23B2.23B1B612.57M423.92M216.34M
Debt / Equity1.11x1.24x0.65x0.52x0.53x0.63x1.71x1.30x1.35x1.25x1.50x1.32x1.24x1.28x1.09x2.88x
Debt / EBITDA4.68x4.60x3.10x2.36x2.61x3.14x7.45x4.35x5.59x5.58x5.67x5.83x5.34x4.41x6.01x-
Net Debt / EBITDA4.37x4.37x2.99x2.21x2.45x2.89x6.59x4.21x5.50x5.46x5.57x5.80x4.88x4.37x5.39x-
Interest Coverage-5.69x-6.68x3.94x0.69x6.36x4.58x2.16x1.68x1.36x2.49x2.45x3.01x3.58x3.30x2.10x-3.19x
Total Equity2.25B2.14B3.19B2.89B2.9B2.58B1.9B2.51B2.36B2.6B2.19B1.7B880.97M480.71M432.55M96.36M
Equity Growth %-128.14%-32.92%10.5%-0.46%12.32%35.98%-24.18%6.07%-8.98%18.75%28.7%92.75%83.26%11.13%348.87%-
Book Value per Share24.5523.6034.6631.7531.6928.4521.4428.5327.0629.8125.4224.8315.929.5611.185.14
Total Shareholders' Equity2.02B1.95B3.07B2.78B2.81B2.52B1.9B2.51B2.33B2.57B2.17B1.69B880.97M480.71M432.55M96.36M
Common Stock909K905K918K913K899K890K880K877K874K871K867K707K592K501K499K321K
Retained Earnings-716.32M-765.84M387.33M131.72M153.39M-119.75M-310.39M361.75M252.82M428.57M220.14M220.99M101.44M18.4M-24.18M-44.58M
Treasury Stock0000000000000000
Accumulated OCI000000-371.37M-414.88M-462.38M-374.12M-549.57M-104.65M-68.37M-29.29M-24.18M-5.82M
Minority Interest229.88M191.59M117.12M105.69M88.26M65.39M0028.81M22.42M17.75M8.05M0000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Litigation and labor costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Shrinks Amid Legal Overhang

Total assets contracted from $6.4B in Q3 2025 to $5.5B in Q2 2026, while equity halved to $2.0B, reflecting a $1.2B loss in Q4 2025, as per recent SEC filings.

The sharp decline in equity, from $3.1B to $2.0B, appears driven by a massive non-recurring charge in Q4 2025, likely related to legal settlements or impairments. This has weakened the balance sheet's capacity to absorb future shocks, though the current ratio improved to 1.57, suggesting adequate short-term liquidity. Investors should monitor whether further charges erode equity further.

Leverage Spikes as Debt Load Grows

Total debt rose to $2.6B in Q2 2026 from $2.0B a year earlier, lifting D/E to 1.17 from 0.64, indicating increased leverage, as reported in quarterly financial statements.

The D/E ratio nearly doubled year-over-year, but this is partly due to the equity base halving rather than a dramatic increase in absolute debt. The absolute debt increase of $600M suggests funding for operations or settlements, not growth, given CapEx cuts. With cash of only $171M, the company appears to rely on debt for liquidity, which may raise refinancing risk if credit conditions tighten.

Asset Mix Shifts to Heavier PPE

PPE net grew to $3.2B in Q2 2026 from $2.5B in Q2 2024, while goodwill fell from $2.3B to $1.3B, indicating a shift toward tangible assets, based on balance sheet data.

The $1.0B reduction in goodwill likely reflects an impairment charge, which is consistent with the Q4 2025 loss. Meanwhile, PPE expansion suggests continued investment in facilities, but the slowdown in CapEx to 4.5% of revenue in Q2 2026 implies this trend may not persist. The asset mix is becoming more tangible, which could improve collateral value but also signals a potential overcapacity if occupancy remains constrained by labor shortages.

Retained Earnings Deepen Deficit

Retained earnings swung from a positive $411.7M in Q3 2025 to a deficit of -$750.8M in Q2 2026, reflecting cumulative losses, as per recent balance sheet filings.

The swing of over $1.1B in retained earnings underscores the magnitude of the Q4 2025 charge, which appears to be a non-cash impairment or legal accrual. This has eroded the equity buffer, leaving the company with negative retained earnings. While no dividends or buybacks were paid, the lack of capital returns is prudent given the need to preserve cash, but the equity quality is now strained.

Liquidity Improves but Cash Buffer Thin

Current ratio rose to 1.57 in Q2 2026 from 1.18 in Q2 2024, yet cash of $171M covers only about 8% of total debt, as reported in financial statements.

The improvement in current ratio suggests better working capital management, but the absolute cash position remains modest relative to debt and operating needs. With operating cash flow of $162M in Q2 2026, the company can cover near-term obligations, but the thin cash buffer leaves little room for unexpected legal settlements or labor cost spikes. Investors should monitor whether cash generation remains sufficient to service debt.

Goodwill Impairment Masks Core Value

Goodwill dropped by $1.0B to $1.3B in Q2 2026, likely reflecting an impairment that distorts the balance sheet's true economic picture, as per recent 10-Q filings.

The impairment appears tied to the Q4 2025 loss, but it may not reflect a permanent decline in the underlying business value, given the JV moat and stable revenue. However, the remaining $1.3B goodwill still represents a significant intangible asset that could be at risk if operational performance deteriorates further. This distortion makes the reported equity understated, and investors should adjust for non-recurring charges when assessing the balance sheet's health.

ACHC — Frequently Asked Questions

Quick answers to the most common questions about buying ACHC stock.

What are the total assets of Acadia Healthcare Company, Inc. (ACHC)?

As of 2025, Acadia Healthcare Company, Inc. (ACHC) had total assets of $5.53B including $814.1M in current assets.

How much debt does Acadia Healthcare Company, Inc. (ACHC) have?

Acadia Healthcare Company, Inc. (ACHC) carries total debt of $2.65B, offset by $133.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Acadia Healthcare Company, Inc.?

Acadia Healthcare Company, Inc. (ACHC) has total shareholders' equity (book value) of $1.95B ($23.60 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Acadia Healthcare Company, Inc.'s current ratio and liquidity?

Acadia Healthcare Company, Inc. (ACHC) reported a current ratio of 1.55x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.